000 01171 a2200301 4500
005 20250517162145.0
264 0 _c20190415
008 201904s 0 0 eng d
022 _a1477-0970
024 7 _a10.1177/1352458517719151
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYap, Siew Mei
245 0 0 _aImmediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis - Not always self-limiting, fully reversible or predictable.
_h[electronic resource]
260 _bMultiple sclerosis (Houndmills, Basingstoke, England)
_c04 2018
300 _a552-553 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAlemtuzumab
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aHumans
650 0 4 _aMultiple Sclerosis
650 0 4 _aMultiple Sclerosis, Relapsing-Remitting
650 0 4 _aThrombocytopenia
700 1 _aMcNicholas, Nuala
700 1 _aHutchinson, Michael
700 1 _aMcGuigan, Christopher
773 0 _tMultiple sclerosis (Houndmills, Basingstoke, England)
_gvol. 24
_gno. 4
_gp. 552-553
856 4 0 _uhttps://doi.org/10.1177/1352458517719151
_zAvailable from publisher's website
999 _c27322780
_d27322780